SUBSCRIBERS

Mega deals morph into mega problems for Wall Street

Tie-ups that consolidate industries, move tax dollars offshore have been met with antitrust, legal challenges

Published Thu, Apr 7, 2016 · 09:50 PM

New York

IF 2015 was a dream year for Wall Street's top dealmakers, 2016 is starting to take a nightmarish turn.

Some of the mega transactions that had champagne corks popping in boardrooms are running into antitrust problems and, in the case of pharmaceutical firm Pfizer's US$160 billion takeover of rival Allergan PLC, political opposition to a deal that envisaged the biggest drug company in the United States moving to Ireland to lower its taxes.

The …

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

International

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here